ALPHS — Pharmasimple SA Cashflow Statement
0.000.00%
Last trade - 00:00TechnologyHighly SpeculativeMicro Cap
Annual cashflow statement for Pharmasimple SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2016 December 31st | 2017 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | Interim Report | Interim Report |
| Standards: | BAS | BAS |
| Status: | Final | Final |
| Net Income/Starting Line | -0.941 | -1.37 |
| Depreciation | ||
| Changes in Working Capital | -0.765 | -1.85 |
| Change in Accounts Receivable | ||
| Change in Inventories | ||
| Change in Other Assets | ||
| Change in Other Liabilities | ||
| Net Change in Other Assets & Liabilities | ||
| Other Operating Cash Flow | ||
| Cash from Operating Activities | -1.44 | -2.9 |
| Capital Expenditures | -0.481 | — |
| Purchase of Fixed Assets | ||
| Other Investing Cash Flow Items | — | 0 |
| Sale of Fixed Assets | ||
| Cash from Investing Activities | -0.481 | 0 |
| Financing Cash Flow Items | — | -0.077 |
| Other Financing Cash Flow | ||
| Net Issuance / Retirement of Stock | ||
| Net Issuance / Retirement of Debt | ||
| Cash from Financing Activities | 1.93 | 5.71 |
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | 0.013 | 2.81 |